Nanoviricides (NNVC) Price to Book (2011 - 2026)
Nanoviricides' (NNVC) quarterly Price to Book came in at 2.16 in Q1 2026, up 1.32% year-over-year from 2.13 in Q1 2025, and down 2.14% quarter-over-quarter from 2.2 in Q4 2025.
Analysis
Nanoviricides (NNVC) Price to Book (2011 - 2026) Analysis & Trends
Nanoviricides has disclosed Price to Book across 16 years of filings, most recently posting 2.16 for Q1 2026.
- In Q1 2026, Price to Book rose 1.32% year-over-year to 2.16; the TTM figure through Mar 2026 stood at 2.16 (up 1.32% YoY), while the FY2025 annual figure was 3.09, up 56.83% from the prior year.
- Price to Book came in at 2.16 for Q1 2026 at Nanoviricides, down from 2.2 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 3.5 in Q3 2025 to a low of 0.65 in Q4 2022.
- Average Price to Book over 5 years is 1.64, with a median of 1.29 recorded in 2024.
- Year-over-year, Price to Book slumped 59.91% in 2022 and jumped 123.18% in 2024.
- Over 5 years, Price to Book stood at 0.65 in 2022, then jumped by 48.46% to 0.96 in 2023, then jumped by 123.18% to 2.15 in 2024, then rose by 2.35% to 2.2 in 2025, then dropped by 2.14% to 2.16 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 2.16 in Q1 2026, 2.2 in Q4 2025, and 3.5 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nanoviricides | 22.04 Mn | 18.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 |
| Dec 31, 2025 | 2.20 |
| Sep 30, 2025 | 3.50 |
| Jun 30, 2025 | 3.09 |
| Mar 31, 2025 | 2.13 |
| Dec 31, 2024 | 2.15 |
| Sep 30, 2024 | 2.09 |
| Jun 30, 2024 | 1.97 |
| Mar 31, 2024 | 1.29 |
| Dec 31, 2023 | 0.96 |
| Sep 30, 2023 | 1.21 |
| Jun 30, 2023 | 0.90 |
| Mar 31, 2023 | 0.75 |
| Dec 31, 2022 | 0.65 |
| Sep 30, 2022 | 0.93 |
| Jun 30, 2022 | 0.94 |
| Mar 31, 2022 | 0.98 |
| Dec 31, 2021 | 1.62 |
| Sep 30, 2021 | 1.89 |
| Jun 30, 2021 | 1.79 |